Mini Review
Accepted on 10 Nov 2025
Engineering with Care: Safety Assessment Platforms for CRISPR-Modified Natural Killer cells
in Cancer Immunity and Immunotherapy
- 389 views
Mini Review
Accepted on 10 Nov 2025
in Cancer Immunity and Immunotherapy
Systematic Review
Accepted on 10 Nov 2025
in Public Mental Health
Original Research
Accepted on 10 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 10 Nov 2025
in Injury Prevention and Control
Review
Accepted on 10 Nov 2025
in Molecular Bacterial Pathogenesis
Original Research
Accepted on 10 Nov 2025
in Mucosal Immunity
Original Research
Accepted on 10 Nov 2025
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 10 Nov 2025
in Mood Disorders
Original Research
Accepted on 10 Nov 2025
in Diabetes Clinical Epidemiology
Original Research
Accepted on 10 Nov 2025
in Radiation Oncology
Review
Accepted on 10 Nov 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 10 Nov 2025
in Infectious Agents and Disease
Brief Research Report
Accepted on 10 Nov 2025
in Work, Employment and Organizations
Review
Accepted on 10 Nov 2025
in Integrative and Regenerative Pharmacology
Original Research
Accepted on 10 Nov 2025
in Diabetes Clinical Epidemiology
Original Research
Accepted on 10 Nov 2025
in Sociology of Stratification